Author details

Full Name

Rong Hu

Affiliation

ORCID

Career Start Year

1994

Papers

189

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
37036883	MmuPV1 E7's interaction with PTPN14 delays Epithelial differentiation and contributes to virus-induced skin disease.		2023
37845234	Genome-wide analysis of the interplay between chromatin-associated RNA and 3D genome organization in human cells.	Nat Commun	2023
36968227	Inhibiting IGF1R-mediated Survival Signaling in Head and Neck Cancer with the Peptidomimetic SSTN.		2023
37081156	Topologically associating domain boundaries are required for normal genome function.	Commun Biol	2023
37071996	Dynamic changes in P300 enhancers and enhancer-promoter contacts control mouse cardiomyocyte maturation.	Dev Cell	2023
37322178	SALL1 enforces microglia-specific DNA binding and function of SMADs to establish microglia identity.	Nat Immunol	2023
36562110	Conditional gene regulation models demonstrate a pro-proliferative role for growth hormone receptor in prostate cancer.		2023
36686648	YIV-906 enhances nuclear factor of activated T-cells (NFAT) activity of T cells and promotes immune checkpoint blockade antibody action and CAR T-cell activity.		2022
35834096	NKX3.1 Expression in Salivary Gland "Intraductal" Papillary Mucinous Neoplasm: A Low-Grade Subtype of Salivary Gland Mucinous Adenocarcinoma.	Head and Neck Pathology	2022
35446279	Prospective Study of PET/MRI Tumor Response During Chemoradiotherapy for Patients With Low-risk and Intermediate-risk p16-positive Oropharynx Cancer.	American Journal of Clinical Oncology: Cancer Clinical Trials	2022
35383352	GH Action in Prostate Cancer Cells Promotes Proliferation, Limits Apoptosis, and Regulates Cancer-related Gene Expression.	Endocrinology	2022
36351387	Systematic discovery and functional dissection of enhancers needed for cancer cell fitness and proliferation.	Cell Rep	2022
35621713	Stress Keratin 17 Expression in Head and Neck Cancer Contributes to Immune Evasion and Resistance to Immune-Checkpoint Blockade.	Clinical Cancer Research	2022
34524848	Parallel characterization of cis-regulatory elements for multiple genes using CRISPRpath.	Sci Adv	2021
33910584	Impact of immediate cryopreservation on the establishment of patient derived xenografts from head and neck cancer patients.	Journal of Translational Medicine	2021
33690977	An NRP1/MDM2-Targeted D-Peptide Supramolecular Nanomedicine for High-Efficacy and Low-Toxic Liver Cancer Therapy.	Advanced healthcare materials	2021
34285037	Overproduction of Gastrointestinal 5-HT Promotes Colitis-Associated Colorectal Cancer Progression via Enhancing NLRP3 Inflammasome Activation.	Cancer Immunology Research	2021
34002095	CTCF mediates dosage- and sequence-context-dependent transcriptional insulation by forming local chromatin domains.	Nat Genet	2021
34188068	YIV-906 potentiated anti-PD1 action against hepatocellular carcinoma by enhancing adaptive and innate immunity in the tumor microenvironment.	Sci Rep	2021
34087454	Blockade of IDO-Kynurenine-AhR Axis Ameliorated Colitis-Associated Colon Cancer via Inhibiting Immune Tolerance.	Cellular and Molecular Gastroenterology and Hepatology	2021
33211402	Fine needle aspiration of salivary gland carcinomas with high-grade transformation: A multi-institutional study of 22 cases and review of the literature.	Cancer cytopathology	2021
33398174	Promoter-proximal CTCF binding promotes distal enhancer-dependent gene activation.	Nat Struct Mol Biol	2021
34461576	LncRNA expression and SDHB mutations in pheochromocytomas and paragangliomas.	Annals of Diagnostic Pathology	2021
32836178	Ki67 index and mitotic count: Correlation and variables affecting the accuracy of the quantification in endocrine/neuroendocrine tumors.	Annals of Diagnostic Pathology	2020
31954771	Flumethasone enhances the efficacy of chemotherapeutic drugs in lung cancer by inhibiting Nrf2 signaling pathway.	Cancer Letters	2020
31785531	HEATR1 deficiency promotes pancreatic cancer proliferation and gemcitabine resistance by up-regulating Nrf2 signaling.	Redox Biology	2020
31628837	Clinicopathologic Characterization of Post-Renal Transplantation BK Polyomavirus-Associated Urothelial CarcinomaSingle Institutional Experience.	American Journal of Clinical Pathology	2020
32298810	Fibroblast Growth Factor Receptors as Targets for Radiosensitization in Head and Neck Squamous Cell Carcinomas.	Int J Radiat Oncol Biol Phys	2020
32439698	AXL Mediates Cetuximab and Radiation Resistance Through Tyrosine 821 and the c-ABL Kinase Pathway in Head and Neck Cancer.	Clinical Cancer Research	2020
32907935	Dynamic structural order of a low-complexity domain facilitates assembly of intermediate filaments.	Proceedings of the National Academy of Sciences of the United States of America	2020
32725507	Long Noncoding RNA Expression in Adrenal Cortical Neoplasms.	Endocrine Pathology	2020
30778236	Dynamic reorganization of the genome shapes the recombination landscape in meiotic prophase.	Nat Struct Mol Biol	2019
31783584	ROCK2 Confers Acquired Gemcitabine Resistance in Pancreatic Cancer Cells by Upregulating Transcription Factor ZEB1.	Cancers	2019
31727856	Brain cell type-specific enhancer-promoter interactome maps and disease<b>-</b>risk association.	Science	2019
30267779	Expression pattern of androgen receptor and AR-V7 in androgen-deprivation therapy-naÃ¯ve salivary duct carcinomas.	Human Pathology	2019
29987694	Sclerosing Microcystic Adenocarcinoma: Report of a Rare Case and Review of Literature.	Head and Neck Pathology	2019
30640711	Effects of Jaeumkanghwa-tang on tamoxifen responsiveness in preclinical ER+ breast cancer model.		2019
29280854	Spermatocytic Seminoma: A Report of 85 Cases Emphasizing Its Morphologic Spectrum Including Some Aspects Not Widely Known.	American Journal of Surgical Pathology	2019
30735911	Digoxin sensitizes gemcitabine-resistant pancreatic cancer cells to gemcitabine via inhibiting Nrf2 signaling pathway.	Redox Biology	2019
31427791	Transcriptionally active HERV-H retrotransposons demarcate topologically associating domains in human pluripotent stem cells.	Nat Genet	2019
30953357	AIM2 promotes non-small-cell lung cancer cell growth through inflammasome-dependent pathway.	Journal of Cellular Physiology	2019
30731273	Personalized Treatment for Lacrimal Sac Adenoid Cystic Carcinoma: Case Report and Literature Review.	Pract Radiat Oncol	2019
31210372	Absent in melanoma 2 suppresses epithelial-mesenchymal transition via Akt and inflammasome pathways in human colorectal cancer cells.	Journal of Cellular Biochemistry	2019
29779944	Analysis of Genetically Diverse Macrophages Reveals Local and Domain-wide Mechanisms that Control Transcription Factor Binding and Function.	Cell	2018
30345078	Autophagy and unfolded protein response (UPR) regulate mammary gland involution by restraining apoptosis-driven irreversible changes.	Cell Death Discovery	2018
29607498	1-L-MT, an IDO inhibitor, prevented colitis-associated cancer by inducing CDC20 inhibition-mediated mitotic death of colon cancer cells.	International Journal of Cancer	2018
29743639	Majority of Chinese Medicine Herb Category "Qing Re Yao" Have Multiple Mechanisms of Anti-inflammatory Activity.	Scientific Reports	2018
29416017	Fasudil increases temozolomide sensitivity and suppresses temozolomide-resistant glioma growth via inhibiting ROCK2/ABCG2.	Cell Death and Disease	2018
27818240	Gen-27, a newly synthesized flavonoid, inhibits glycolysis and induces cell apoptosis via suppression of hexokinase II in human breast cancer cells.	Biochemical Pharmacology	2017
28942022	X-11-5-27, a daidzein derivative, inhibits NLRP3 inflammasome activity via promoting autophagy.	Experimental Cell Research	2017